Propofol

Generic Name
Propofol
Brand Names
Diprivan
Drug Type
Small Molecule
Chemical Formula
C12H18O
CAS Number
2078-54-8
Unique Ingredient Identifier
YI7VU623SF
Background

Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. ...

Indication

Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.

Associated Conditions
-
Associated Therapies
Induction of anesthesia therapy, Maintenance of anesthesia therapy, Monitored anesthesia care sedation, Sedative therapy

Cyclopofol Versus Propofol for Postoperative Delirium in Elderly Patients Having Orthopedic Surgery

Phase 4
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-09-21
Last Posted Date
2023-09-21
Lead Sponsor
RenJi Hospital
Target Recruit Count
60
Registration Number
NCT06046638

Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA

First Posted Date
2023-09-13
Last Posted Date
2023-09-13
Lead Sponsor
Scarlata, Simone, M.D.
Target Recruit Count
30
Registration Number
NCT06033729
Locations
🇮🇹

Università Campus Bio Medico, Roma, Italy

Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study

First Posted Date
2023-09-13
Last Posted Date
2024-04-08
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
260
Registration Number
NCT06036095
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study

First Posted Date
2023-08-30
Last Posted Date
2023-08-30
Lead Sponsor
University of Kansas Medical Center
Target Recruit Count
80
Registration Number
NCT06017141
Locations
🇺🇸

University of Kansas Cancer Center, Kansas City, Kansas, United States

Ciprofol vs Propofol for Reducing Hypoxia Incidence in ERCP

Not Applicable
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-08-29
Last Posted Date
2024-05-31
Lead Sponsor
RenJi Hospital
Target Recruit Count
136
Registration Number
NCT06015074
Locations
🇨🇳

Renji Hospital, Shanghai Jiao Tong University School of Medicine,, Shanghai, Shanghai, China

Volatile Sedation for Patients With the Acute Respiratory Distress Syndrome

First Posted Date
2023-08-28
Last Posted Date
2024-03-06
Lead Sponsor
Guy's and St Thomas' NHS Foundation Trust
Target Recruit Count
20
Registration Number
NCT06014138
Locations
🇬🇧

Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom

COnventional vs. Optimised PERiprocedural Analgosedation vs. Total IntraVEnous Anaesthesia for Pulsed-Field Ablation (COOPERATIVE-PFA)

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2023-08-28
Last Posted Date
2023-11-28
Lead Sponsor
Charles University, Czech Republic
Target Recruit Count
126
Registration Number
NCT06013345
Locations
🇨🇿

University Hospital Kralovske Vinohrady, Prague, Czechia

The Dose Range of Remimazolam Besylate in Different Age Groups

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2023-08-24
Last Posted Date
2023-09-06
Lead Sponsor
Tongji Hospital
Target Recruit Count
1876
Registration Number
NCT06009991
Locations
🇨🇳

ongji Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan, Hubei, China

Effects of Remimazolam and Propofol on Anesthesia Induction

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2023-08-24
Last Posted Date
2024-01-25
Lead Sponsor
Zheng Guo
Target Recruit Count
80
Registration Number
NCT06009055
Locations
🇨🇳

econd of Shanxi Medical University, Taiyuan, Shanxi, China

The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients

Not Applicable
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-08-22
Last Posted Date
2023-08-28
Lead Sponsor
RenJi Hospital
Target Recruit Count
600
Registration Number
NCT06004843
Locations
🇨🇳

Renji Hospital, Shanghai, Pudong New Area, China

© Copyright 2024. All Rights Reserved by MedPath